Prescription Opioid Use among Adults with Mental Health Disorders in the United States

Prescription Opioid Use among Adults with Mental Health Disorders in the United States
复制标题

DOI:
10.3122/jabfm.2017.04.170112
复制
发表时间:
2017-07-01
影响因子:
2.9
通讯作者:
Sites, Brian D.
Sites, Brian D.
中科院分区:
医学3区
文献类型:
--
作者:
Davis, Matthew A.;Lin, Lewei A.;Sites, Brian D.

文献摘要

被引文献

相似文献

背景资料:在多大程度上,在美国的精神健康障碍的成年人接受阿片类药物还没有得到充分reported.Methods:我们进行了一项横断面研究的全国代表性样本的非制度化的美国成年人口的医疗支出小组调查。我们研究了精神健康(情绪和焦虑)障碍和处方阿片类药物使用(定义为在一个日历年内至少接受2个处方)之间的关系。结果:我们估计,在3860万美国精神健康障碍患者中,18.7%(3860万中的720万)使用处方阿片类药物。有精神健康状况的成年人每年接受美国阿片类药物处方总量的51.4%(1.15亿处方中的6000万处方)。与没有心理健康障碍的成年人相比,有心理健康障碍的成年人更有可能使用阿片类药物(18.7% vs 5.0%; P < .001)。在调整后的分析中,有心理健康障碍与处方阿片类药物的使用总体(比值比,2.08; 95%置信区间,1.83-2.35)。结论:16%的美国人谁有心理健康障碍收到超过一半的所有阿片类药物在美国规定。改善这一人群的疼痛管理对于减少国家对阿片类药物的依赖至关重要。
Background: The extent to which adults with mental health disorders in the United States receive opioids has not been adequately reported.Methods: We performed a cross-sectional study of a nationally representative sample of the noninstitutionalized U.S. adult population from the Medical Expenditure Panel Survey. We examined the relationship between mental health (mood and anxiety) disorders and prescription opioid use (defined as receiving at least 2 prescriptions in a calendar year).Results: We estimate that among the 38.6 million Americans with mental health disorders, 18.7% (7.2 million of 38.6 million) use prescription opioids. Adults with mental health conditions receive 51.4% (60 million of 115 million prescriptions) of the total opioid prescriptions distributed in the United States each year. Compared with adults without mental health disorders, adults with mental health disorders were significantly more likely to use opioids (18.7% vs 5.0%; P < .001). In adjusted analyses, having a mental health disorder was associated with prescription opioid use overall (odds ratio, 2.08; 95% confidence interval, 1.83-2.35).Conclusions: The 16% of Americans who have mental health disorders receive over half of all opioids prescribed in the United States. Improving pain management among this population is critical to reduce national dependency on opioids.